Injective vs Celestia Staking
Side-by-side comparison of INJ and TIA staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Injective vs Celestia: which should you stake?
Injective currently offers the higher APY at 6.39% compared to Celestia's 5.22%. That's a 1.17 percentage point difference in annual yield.
In terms of market cap, Injective is the larger asset at $299.30M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Injective vs Celestia — common questions
Is Injective or Celestia better for staking?
Injective currently offers a higher staking APY at 6.39% compared to Celestia's 5.22%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Injective and Celestia?
Injective offers 6.39% APY while Celestia offers 5.22% APY — a difference of 1.17 percentage points.
Which is safer to stake: INJ or TIA?
Injective has a medium risk rating while Celestia has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both INJ and TIA?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Injective and Celestia spreads your risk across different networks and protocols.